TCL Archive FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI April 15, 1977
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection August 12, 1983
TCL Archive More money would speed progress, NCI says, but backs off previous commitment to meet 2015 goal by 2010. July 29, 2005
